Personalized Therapy for Multiple Myeloma

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Personalized Therapy for Multiple Myeloma by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319618722
Publisher: Springer International Publishing Publication: October 30, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319618722
Publisher: Springer International Publishing
Publication: October 30, 2017
Imprint: Springer
Language: English

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

More books from Springer International Publishing

Cover of the book Risk Assessment and Risk-Driven Quality Assurance by
Cover of the book Abstract State Machines, Alloy, B, TLA, VDM, and Z by
Cover of the book Computational Methods for Processing and Analysis of Biological Pathways by
Cover of the book Intelligent Robotics and Applications by
Cover of the book Virtual Reality and Augmented Reality by
Cover of the book Perpetrators in Holocaust Narratives by
Cover of the book Flexibility of Group Actions on the Circle by
Cover of the book Metastatic Neoplasms in Fine-Needle Aspiration Cytology by
Cover of the book Micro-Electrode-Dot-Array Digital Microfluidic Biochips by
Cover of the book Advanced Data Mining and Applications by
Cover of the book Clinician’s Guide to Breastfeeding by
Cover of the book Aniridia by
Cover of the book Mind, Values, and Metaphysics by
Cover of the book Handbook on Project Management and Scheduling Vol. 2 by
Cover of the book Umbilicus and Umbilical Cord by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy